The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
Danaher boosts product portfolio with the acquisition of Masimo
Danaher Corporation DHR has completed the acquisition of Masimo Corp. for $180 per share in cash. The transaction was valued at approximately $9.9 billion in total, including assumed debt and net of ...
Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Phil Ryan Phil Ryan is a writer primarily covering photography gear, printers, ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
The WSJ/College Pulse 2025 Best Colleges in the U.S. ranking rates the top 500 universities in the country. The ranking was developed and executed in collaboration with our research partners College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results